NDC codes

FDA NDC Directory
Product NDC (as listed)60505-0095Labeler and product segments. Claims need a package NDC.
Product NDC at billing width60505-0095Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
60505-0095-06050500950060505009500100 TABLET in 1 BOTTLE (60505-0095-0)Marketed from Jul 14, 2011
60505-0095-160505009501605050095011000 TABLET in 1 BOTTLE (60505-0095-1)Marketed from Jul 14, 2011

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Doxazosin
Generic name (nonproprietary)
doxazosin
Active ingredients
Doxazosin mesylate — 4 mg/1
Dosage form
Tablet
Route
Oral
Labeler
Apotex Corp.NDC labeler code 60505
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 075580
Marketing start
Listing expires
Other FDA classes
Adrenergic alpha-Antagonists (Mechanism)
Identifiers
Product ID 60505-0095_81f80a89-6a61-35db-36ad-3cb9d7ecfbdcSPL ID 81f80a89-6a61-35db-36ad-3cb9d7ecfbdc
Pharmacologic class
alpha-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N460505009500 followed by a unit qualifier and the quantity

Package 60505-0095-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

About NDC 60505-0095

What is NDC 60505-0095?
60505-0095 is the product NDC for Doxazosin, Doxazosin mesylate 4 mg/1 tablet, listed with the FDA by Apotex Corp.. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
Doxazosin.
What is the active ingredient?
Doxazosin mesylate.
Who is the labeler?
Apotex Corp., NDC labeler code 60505. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Doxazosin?
106 other product NDCs are listed under this name. See all Doxazosin NDCs.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Doxazosin NDCs
ProductStrengthForm · routeLabelerProduct NDCPackage NDCs (11-digit)
DoxazosinDoxazosin mesylate 2 mg/1TabletOralRising Pharma Holdings, Inc.16571-16616571-0166-01
DoxazosinDoxazosin mesylate 1 mg/1TabletOralRising Pharma Holdings, Inc.16571-16516571-0165-01
DoxazosinDoxazosin mesylate 4 mg/1TabletOralRising Pharma Holdings, Inc.16571-16716571-0167-01
DoxazosinDoxazosin mesylate 8 mg/1TabletOralRising Pharma Holdings, Inc.16571-16816571-0168-01
Doxazosindoxazosin mesylateDoxazosin mesylate 1 mg/1TabletOralAurobindo Pharma Limited59651-89259651-0892-0159651-0892-99
Doxazosindoxazosin mesylateDoxazosin mesylate 2 mg/1TabletOralAurobindo Pharma Limited59651-89359651-0893-0159651-0893-99
Doxazosindoxazosin mesylateDoxazosin mesylate 4 mg/1TabletOralAurobindo Pharma Limited59651-89459651-0894-0159651-0894-99
Doxazosindoxazosin mesylateDoxazosin mesylate 8 mg/1TabletOralAurobindo Pharma Limited59651-89559651-0895-0159651-0895-99
DoxazosinDoxazosin mesylate 4 mg/1TabletOralREMEDYREPACK INC.70518-403170518-4031-00
DoxazosinDoxazosin mesylate 2 mg/1TabletOralREMEDYREPACK INC.70518-396570518-3965-0070518-3965-01

All 107 Doxazosin NDCs

Other NDCs under ANDA 075580

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 075580
ProductStrengthForm · routeLabelerProduct NDC
DoxazosinDoxazosin mesylate 1 mg/1TabletOralMajor Pharmaceuticals0904-5522
DoxazosinDoxazosin mesylate 2 mg/1TabletOralMajor Pharmaceuticals0904-5523
DoxazosinDoxazosin mesylate 4 mg/1TabletOralMajor Pharmaceuticals0904-5524
DoxazosinDoxazosin mesylate 2 mg/1TabletOralAvKARE42291-258
DoxazosinDoxazosin mesylate 4 mg/1TabletOralAvKARE42291-259
DoxazosinDoxazosin mesylate 8 mg/1TabletOralAvKARE42291-260
DoxazosinDoxazosin mesylate 2 mg/1TabletOralPD-Rx Pharmaceuticals, Inc.43063-739
DoxazosinDoxazosin mesylate 1 mg/1TabletOralA-S Medication Solutions50090-0701
DoxazosinDoxazosin mesylate 2 mg/1TabletOralA-S Medication Solutions50090-0704
DoxazosinDoxazosin mesylate 1 mg/1TabletOralAvPAK50268-222
DoxazosinDoxazosin mesylate 2 mg/1TabletOralAvPAK50268-223
DoxazosinDoxazosin mesylate 4 mg/1TabletOralAvPAK50268-224
DoxazosinDoxazosin mesylate 8 mg/1TabletOralAvPAK50268-225
DoxazosinDoxazosin mesylate 1 mg/1TabletOralNorthwind Health Company, LLC51655-476
DoxazosinDoxazosin mesylate 2 mg/1TabletOralCardinal Health 107, LLC55154-7996
DoxazosinDoxazosin mesylate 1 mg/1TabletOralApotex Corp.60505-0093
DoxazosinDoxazosin mesylate 2 mg/1TabletOralApotex Corp.60505-0094
DoxazosinDoxazosin mesylate 8 mg/1TabletOralApotex Corp.60505-0096
DoxazosinDoxazosin mesylate 4 mg/1TabletOralNuCare Pharmaceuticals, Inc.68071-3298
DoxazosinDoxazosin mesylate 2 mg/1TabletOralNuCare Pharmaceuticals, Inc.68071-3341

Showing 20 of 33.

Free account

Log in to keep searching

You’ve used your 3 free searches. Med-Code is free: log in or create a free profile to keep looking up NDCs, J-codes and drugs.

Create a free profileLog in